EL vs KVUE
EL: A prestige beauty conglomerate struggling to stabilize margins while navigating restructuring and shifting consumer demand across skincare, cosmetics, and fragrance. KVUE: The world's largest pure-play consumer health company, leveraging a portfolio of iconic brands like Tylenol, Listerine, and Neutrogena across self-care, skin health, and essential health categories.
Side-by-side fundamentals
| Metric | EL | KVUE | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $81.99 | $19.18 | |
| Market cap as of 2026-07-10 | $29.7B | $36.8B | |
| P/E as of 2026-07-10 | n/a | 22.70 | |
| PEG as of 2026-07-10 | 0.68 | 2.72 | EL lower |
| Net margin as of 2026-07-10 | -1.7% | +10.6% | KVUE higher |
| Gross margin as of 2026-07-10 | +74.7% | +58.9% | EL higher |
| Operating margin as of 2026-07-10 | +2.9% | +17.1% | KVUE higher |
| ROE as of 2026-07-10 | -6.3% | +15.2% | KVUE higher |
| ROA as of 2026-07-10 | -1.3% | +6.0% | KVUE higher |
| Debt / equity as of 2026-07-10 | 1.83 | 0.82 | KVUE lower |
| Revenue growth (YoY) as of 2026-07-10 | +0.3% | -0.1% | EL higher |
| Revenue CAGR (3y) SEC XBRL | -6.9% | +0.2% | KVUE higher |
| Dividend yield as of 2026-07-10 | +1.7% | +4.3% | KVUE higher |
| Dividend streak (yrs) SEC XBRL | 1 | 3 | KVUE higher |
| Beta as of 2026-07-10 | 1.24 | 0.45 | |
| 1-year return as of 2026-07-09 close | -5.3% | -6.8% | EL higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.